High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|6|471-477

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.6, 2015-06, pp. : 471-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contribution of Comparative Genomic Hybridization and Fluorescence in situ Hybridization to the Detection of Chromosomal Abnormalities in B-Cell Chronic Lymphocytic Leukemia

By  

Oncology Research and Treatment, Vol. 24, Iss. 1, 2001-03 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

dup(12)(q13–q22) and 13q14 Deletion in a Case of B-Cell Chronic Lymphocytic Leukemia

By  

Acta Haematologica, Vol. 104, Iss. 4, 2001-03 ,pp. : 197-201

Karger

Access to resources Recommend Favorite

Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib‐based regimens

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3612-3621

John Wiley & Sons Inc

Access to resources Recommend Favorite

Significance of Chromosomal Aberrations in CLL. Concerning Jarošová M, et al.: Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia. Onkologie 2001;24:60–65.

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 176-176

Karger

Access to resources Recommend Favorite

“Double‐hit” chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 375-382

John Wiley & Sons Inc

Access to resources Recommend Favorite